The bustling centre is a hub for shopping and dining, boasting over 90 high-profile brands across its three-storey building, ...
East Allen County Schools officials are closer to knowing the cost of a new school following a second bidding phase that ...
FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...
PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a ...
Samsung Electronics is preparing to enter the final quality testing phase for Nvidia's sixth-generation high-bandwidth memory ...
I-DXd showed a 46.2% intracranial cORR and 90.8% cDCR in ES-SCLC patients with brain metastases. Patients without prior brain radiotherapy had a higher intracranial cORR of 57.7%. The trial included ...
Among patients with small cell lung cancer (SCLC), treatment with Imdelltra (tarlatamab-dlle) was found to improve overall ...
Fruquintinib plus sintilimab significantly improved PFS in advanced RCC patients compared to axitinib or everolimus, with a median PFS of 22.21 months versus 6.90 months. The combination therapy ...
EXECUTIVE CHAIRMAN & CEO OF MEDICUS TO PARTICIPATE IN A FIRESIDE CHAT WITH EQUITY RESEARCH ANALYST PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / October 13, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) ( ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced data from the phase I CLARITY open-label, crossover study, showing ...
"This is just the beginning," Skip Alston, chairman of the Guilford County Board of Commissioners said. "We need at least 10 ...
Beyond its initial phase II trial results, stroke therapy developer Argenica has identified a clear path forward based on new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results